Mitoplasticity: Adaptation biology of the mitochondrion to the cellular redox state in physiology and carcinogenesis

Antioxidants and Redox Signaling

Volumn 18, Issue 7, 2013, Pages 808-849

  Jose, Caroline ^a   Melser, Su ^a   Benard, Giovanni ^a   Rossignol, Rodrigue ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE LKB1; PROTEIN P53; PYRUVATE KINASE; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR FKHRL1;

ADAPTATION; BIOENERGY; BIOSYNTHESIS; CANCER SURVIVAL; CARCINOGENESIS; CELL AGING; CELL CULTURE; CELL ENERGY; CELL FUNCTION; CELL GROWTH; CELL HYPOXIA; CELL VIABILITY; DNA DAMAGE; DNA REPLICATION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; ENVIRONMENTAL STRESS; ENZYME REGULATION; EXERCISE; GENOTOXICITY; GLYCOLYSIS; HOMEOSTASIS; HUMAN; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOPHAGY; MITOPLASTICITY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; HUMANS; MITOCHONDRIA; NEOPLASMS; OXIDATION-REDUCTION;

EID: 84872981312     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4357     Document Type: Review

References (292)

1. Acin-Perez R, Salazar E, Kamenetsky M, Buck J, Levin LR, and Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab 9: 265-276, 2009.
2. Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y, Djouadi F, Miraux S, Thiaudiere E, Foretz M, Viollet B, Diolez P, Bastin J, Benit P, Rustin P, Carling D, Sandri M, Ventura-Clapier R, and Pende M. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab 5: 476-487, 2007.
3. Almeida A, Almeida J, Bolanos JP, and Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astro-cyte protection. Proc Natl Acad Sci USA 98: 15294-15299, 2001.
4. Almeida A, Moncada S, and Bolanos JP. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6: 45-51, 2004.
5. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vi-jayasarathy C, Shephard HM, and Avadhani NG. Mi-tochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21: 7839-7849, 2002.
6. Andris F, Denanglaire S, Baus E, Rongvaux A, Steuve J, Flavell RA, and Leo O. Metabolic stress boosts humoral responses in vivo independently of inflammasome and inflammatory reaction. J Immunol 186: 2245-2253, 2011.
7. Antelman J, Manandhar G, Yi YJ, Li R, Whitworth KM, Sutovsky M, Agca C, Prather RS, and Sutovsky P. Expression of mitochondrial transcription factor A (TFAM) during porcine gametogenesis and preimplantation embryo development. J Cell Physiol 217: 529-543, 2008.
8. Arnould T, Vankoningsloo S, Renard P, Houbion A, Ni-nane N, Demazy C, Remacle J, and Raes M. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. Embo J 21: 53-63, 2002.
9. Atorino L, Silvestri L, Koppen M, Cassina L, Ballabio A, Marconi R, Langer T, and Casari G. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163: 777-787, 2003.
10. Baracca A, Chiaradonna F, Sgarbi G, Solaini G, Alberghina L, and Lenaz G. Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim Biophys Acta 1797: 314-323, 2010.
11. Beau I, Mehrpour M, and Codogno P. Autophagosomes and human diseases. Int J Biochem Cell Biol 43: 460-464, 2011.
12. Beckner ME, Gobbel GT, Abounader R, Burovic F, Agos-tino NR, Laterra J, and Pollack IF. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Invest 85: 1457-1470, 2005.
13. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, and Mazure NM. Hypoxia-induced autop-hagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29: 2570-2581, 2009.
14. Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, and Rossignol R. Mitochondrial bioenergetics and structural network organization. J Cell Sci 120: 838-848, 2007.
15. Benard G, Bellance N, Jose C, and Rossignol R. Relationships Between Mitochondrial Dynamics and Bioenergetics. In: Mitochondrial Dynamics and Neurodegeneration, edited by Lu B. Dordrecht: Springer, 2011.
16. Benard G, Faustin B, Galinier A, Rocher C, Bellance N, Smolkova K, Casteilla L, Rossignol R, and Letellier T. Functional dynamic compartmentalization of respiratory chain intermediate substrates: implications for the control of energy production and mitochondrial diseases. Int J Biochem Cell Biol 40: 1543-1554, 2008.
17. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, Bellance N, Delage JP, Casteilla L, Letellier T, and Rossignol R. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 291: C1172-C1182, 2006.
18. Benard G, Neutzner A, Peng G, Wang C, Livak F, Youle RJ, and Karbowski M. IBRDC2, an IBR-type E3 ubiquitin li-gase, is a regulatory factor for Bax and apoptosis activation. EMBO J 29: 1458-1471, 2010.
19. Benard G and Rossignol R. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 10: 1313-1342, 2008.
20. Benard G, Trian T, Bellance N, Berger P, Lavie J, Espil C, Rocher C, Eimer-Bouillot S, Goizet C, Nouette-Gaulain K, Letellier T, Lacombe D, and Rossignol R. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid Redox Signal, 2012 [Epub ahead of print]; DOI: 10.1089/ars.2011.4244.
21. Benbrik E, Chariot P, Bonavaud S, Ammi-Said M, Frisdal E, Rey C, Gherardi R, and Barlovatz-Meimon G. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci 149: 19-25, 1997.
22. Bensaad K, Cheung EC, and Vousden KH. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J 28: 3015-3026, 2009.
23. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, and Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120, 2006.
24. Biswas G, Adebanjo OA, Freedman BD, Anandatheertha-varada HK, Vijayasarathy C, Zaidi M, Kotlikoff M, and Avadhani NG. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J 18: 522-533, 1999.
25. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, and Michelakis ED. A mitochondria-K + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11: 37-51, 2007.
26. Bourdineaud JP, Bellance N, Benard G, Brethes D, Fujimura M, Gonzalez P, Marighetto A, Maury-Brachet R, Mormede C, Pedron V, Philippin JN, Rossignol R, Rostene W, Sa-wada M, and Laclau M. Feeding mice with diets containing mercury-contaminated fish flesh from French Guiana: a model for the mercurial intoxication of the Wayana Amerindians. Environ Health 7: 53, 2008.
27. Bourdineaud JP, Fujimura M, Laclau M, Sawada M, and Yasutake A. Deleterious effects in mice of fish-associated methylmercury contained in a diet mimicking the Western populations' average fish consumption. Environ Int 37: 303-313, 2011.
28. Bouzier AK, Voisin P, Goodwin R, Canioni P, and Merle M. Glucose and lactate metabolism in C6 glioma cells: evidence for the preferential utilization of lactate for cell oxi-dative metabolism. Dev Neurosci 20: 331-338, 1998.
29. Bravo R, Vicencio JM, Parra V, Troncoso R, Munoz JP, Bui M, Quiroga C, Rodriguez AE, Verdejo HE, Ferreira J, Iglewski M, Chiong M, Simmen T, Zorzano A, Hill JA, Rothermel BA, Szabadkai G, and Lavandero S. Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci 124: 2143-2152, 2011.
30. Burgess SC, Iizuka K, Jeoung NH, Harris RA, Kashiwaya Y, Veech RL, Kitazume T, and Uyeda K. Carbohydrate-response element-binding protein deletion alters substrate utilization producing an energy-deficient liver. J Biol Chem 283: 1670-1678, 2008.
31. Burns DM and Richter JD. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev 22: 3449-3460, 2008.
32. Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzi-vassiliou G, Elstrom RL, and Thompson CB. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. On-cogene 24: 4165-4173, 2005.
33. Cabezon E, Montgomery MG, Leslie AG, and Walker JE. The structure of bovine F1-ATPase in complex with its regulatory protein IF1. Nat Struct Biol 10: 744-750, 2003.
34. Cambier S, Benard G, Mesmer-Dudons N, Gonzalez P, Rossignol R, Brethes D, and Bourdineaud JP. At environmental doses, dietary methylmercury inhibits mitochon-drial energy metabolism in skeletal muscles of the zebra fish (Danio rerio). Int J Biochem Cell Biol 41: 791-799, 2009.
35. Cambier S, Gonzalez P, Mesmer-Dudons N, Brethes D, Fujimura M, and Bourdineaud JP. Effects of dietary methylmercury on the zebrafish brain: histological, mito-chondrial, and gene transcription analyses. Biometals 25: 165-180, 2012.
36. Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, Abramov AY, Tinker A, and Duchen MR. Regulation of mitochondrial structure and function by the F1Fo-AT-Pase inhibitor protein, IF1. Cell Metab 8: 13-25, 2008.
37. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740, 2007.
38. Canto C and Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20: 98-105, 2009.
39. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, and Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060, 2009.
40. Carew JS, Nawrocki ST, Xu RH, Dunner K, McConkey DJ, Wierda WG, Keating MJ, and Huang P. Increased mito-chondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to flu-darabine. Leukemia 18: 1934-1940, 2004.
41. Cereghetti GM and Scorrano L. The many shapes of mi-tochondrial death. Oncogene 25: 4717-4724, 2006.
42. Chami M, Oules B, Szabadkai G, Tacine R, Rizzuto R, and Paterlini-Brechot P. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell 32: 641-651, 2008.
43. Chance B and Williams GR. The respiratory chain and oxidative phophorylation. Adv Enzymol 17: 65-134, 1956.
44. Charni S, de Bettignies G, Rathore MG, Aguilo JI, van den Elsen PJ, Haouzi D, Hipskind RA, Enriquez JA, Sanchez-Beato M, Pardo J, Anel A, and Villalba M. Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway. J Immunol 185: 3498-34503, 2010.
45. Chen V, Staub RE, Fong S, Tagliaferri M, Cohen I, and Shtivelman E. Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS. PLoS One 7: e30300, 2012.
46. Cheung WD and Hart GW. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J Biol Chem 283: 13009-13020, 2008.
47. Chevrollier A, Loiseau D, Chabi B, Renier G, Douay O, Malthiery Y, and Stepien G. ANT2 isoform required for cancer cell glycolysis. J Bioenerg Biomembr 37: 307-316, 2005.
48. Chevrollier A, Loiseau D, Gautier F, Malthiery Y, and Stepien G. ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells. Mol Carcinog 42: 1-8, 2004.
49. Chevrollier A, Loiseau D, Reynier P, and Stepien G. Ade-nine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism. Biochim Biophys Acta 1807: 562-567, 2011.
50. Colombo SL and Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421: 163-169, 2009.
51. Cuezva JM, Ostronoff LK, Ricart J, Lopez de Heredia M, Di Liegro CM, and Izquierdo JM. Mitochondrial biogenesis in the liver during development and oncogenesis. J Bioenerg Biomembr 29: 365-377, 1997.
52. Czech MP and Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Chem 274: 1865-1868, 1999.
53. da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, Takahashi H, Goldberg MS, Shen J, and Checler F. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol 11: 1370-1375, 2009.
54. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, and Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322: 1098-1105, 1990.
55. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabi-nowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, and Su SM. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744, 2009.
56. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabi-nowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, and Su SM. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 465: 966, 2010.
57. de Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, Winer M, Oerlemans F, Pluk H, Fransen JA, and Wieringa B. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer 8: 54, 2009.
58. Demaria M, Giorgi C, Lebiedzinska M, Esposito G, D'Angeli L, Bartoli A, Gough DJ, Turkson J, Levy DE, Watson CJ, Wieckowski MR, Provero P, Pinton P, and Poli V. A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging 2: 823-842, 2010.
59. Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, Finardi A, Cagnoli C, Tempia F, Frontali M, Veneziano L, Sacco T, Boda E, Brussino A, Bonn F, Cas-tellotti B, Baratta S, Mariotti C, Gellera C, Fracasso V, Magri S, Langer T, Plevani P, Di Donato S, Muzi-Falconi M, and Taroni F. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42: 313-321, 2010.
60. Diaz-Ruiz R, Averet N, Araiza D, Pinson B, Uribe-Carvajal S, Devin A, and Rigoulet M. Mitochondrial oxidative phosphorylation is regulated by fructose 1, 6-bisphosphate. A possible role in Crabtree effect induction? J Biol Chem 283: 26948-26955, 2008.
61. Dieteren CE, Gielen SC, Nijtmans LG, Smeitink JA, Swarts HG, Brock R, Willems PH, and Koopman WJ. Solute diffusion is hindered in the mitochondrial matrix. Proc Natl Acad Sci USA 108: 8657-8662, 2011.
62. Ding WX, Ni HM, Li M, Liao Y, Chen X, Stolz DB, Dorn GW, 2nd, and Yin XM. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochon-drial priming. J Biol Chem 285: 27879-27890, 2010.
63. Distelmaier F, Visch HJ, Smeitink JA, Mayatepek E, Koopman WJ, and Willems PH. The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency. J Mol Med 87: 515-522, 2009.
64. Djavaheri-Mergny M, Maiuri MC, and Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 29: 1717-9, 2010.
65. Domenis R, Comelli M, Bisetto E, and Mavelli I. Mitochon-drial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J Bioenerg Biomembr 43: 493-505, 2011.
66. Donnely M and Scheffler I. Energy metabolism in respiration deficient and wild type chinese hamster fibroblasts in culture. J Cell Physiol 89: 39-52, 1976.
67. Duclos M, Martin C, Malgat M, Mazat JP, Chaouloff F, Mormede P, and Letellier T. Relationships between muscle mitochondrial metabolism and stress-induced corticoste-rone variations in rats. Pflugers Arch 443: 218-226, 2001.
68. Dudkina NV, Kudryashev M, Stahlberg H, and Boekema EJ. Interaction of complexes I, III, and IV within the bovine respirasome by single particle cryoelectron tomography. Proc Natl Acad Sci USA 108: 15196-15200, 2011.
69. Dykens JA and Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discov Today 12: 777-785, 2007.
70. Eakin RT, Morgan LO, Gregg CT, and Matwiyoff NA. Carbon-13 nuclear magnetic resonance spectroscopy of living cells and their metabolism of a specifically labeled 13C substrate. FEBS Lett 28: 259-264, 1972.
71. Echtay KS, Murphy MP, Smith RA, Talbot DA, and Brand MD. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antiox-idants. J Biol Chem 277: 47129-47135, 2002.
72. Efremov RG, Baradaran R, and Sazanov LA. The architecture of respiratory complex I. Nature 465: 441-445, 2010.
73. Efremov RG and Sazanov LA. Structure of the membrane domain of respiratory complex I. Nature 476: 414-420, 2011.
74. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, and Shaw RJ. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461, 2011.
75. Ehses S, Raschke I, Mancuso G, Bernacchia A, Geimer S, Tondera D, Martinou JC, Westermann B, Rugarli EI, and Langer T. Regulation of OPA1 processing and mitochon-drial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol 187: 1023-1036, 2009.
76. Faustin B, Rossignol R, Rocher C, Benard G, Malgat M, and Letellier T. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 279: 20411-20421, 2004.
77. Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, and El-Deiry WS. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 6: 597-609, 2004.
78. Fischer B, Muller B, Fisch P, and Kreutz W. An acidic mi-croenvironment inhibits antitumoral non-major histocom-patibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J Immunother 23: 196-207, 2000.
79. Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, and Ruoslahti E. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxida-tive phosphorylation. Mol Cell Biol 30: 1303-1318, 2010.
80. Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, and Tamagawa H. Lovastatin decreases coenzyme Qlevels in humans. Proc Natl Acad Sci USA 87: 8931-8934, 1990.
81. Fryer LG, Foufelle F, Barnes K, Baldwin SA, Woods A, and Carling D. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J 363: 167-174, 2002.
82. Funes JM, Quintero M, Henderson S, Martinez D, Qureshi U, Westwood C, Clements MO, Bourboulia D, Pedley RB, Moncada S, and Boshoff C. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci USA 104: 6223-6228, 2007.
83. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, and Dang CV. c-Myc suppression of miR-23a/b enhances mi-tochondrial glutaminase expression and glutamine metabolism. Nature 458: 762-765, 2009.
84. Gasparre G, Kurelac I, Capristo M, Iommarini L, Ghelli A, Ceccarelli C, Nicoletti G, Nanni P, De Giovanni C, Sco-tlandi K, Betts CM, Carelli V, Lollini PL, Romeo G, Rugolo M, and Porcelli AM. A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function. Cancer Res 71: 6220-6229, 2011.
85. Gatenby RA and Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
86. Gatenby RA and Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer 8: 56-61, 2008.
87. Gatza E, Wahl DR, Opipari AW, Sundberg TB, Reddy P, Liu C, Glick GD, and Ferrara JL. Manipulating the bioen-ergetics of alloreactive T cells causes their selective apo-ptosis and arrests graft-versus-host disease. Sci Transl Med 3: 67ra8, 2011.
88. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, and Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquiti-nated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19: 4861-4870, 2010.
89. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, and Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131, 2010.
90. Gellerich FN, Gizatullina Z, Trumbeckaite S, Korzeniewski B, Gaynutdinov T, Seppet E, Vielhaber S, Heinze HJ, and Striggow F. Cytosolic Ca2 + regulates the energisation of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle. Biochem J443: 747-755, 2012.
91. Giorgio M, Berry A, Berniakovich I, Poletaeva I, Trinei M, Stendardo M, Hagopian K, Ramsey JJ, Cortopassi G, Mi-gliaccio E, Notzli S, Amrein I, Lipp HP, Cirulli F, and Pe-licci PG. The p66Shc knocked out mice are short lived under natural condition. Aging Cell 11: 162-168, 2012.
92. Gnaiger E and Kemp RB. Anaerobic metabolism in aerobic mammalian cells: information from the ratio of calorimetric heat flux and respirometric oxygen flux. Biochim Biophys Acta 1016: 328-332, 1990.
93. Gomes LC, Di Benedetto G, and Scorrano L. During au-tophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 13: 589-598, 2011.
94. Gosalvez M and Merchan J. Letter: induction of rat mammary adenomas with respiratory inhibitory rotenone. Cancer Res 33: 3047-3050, 1973.
95. Gottlieb E and Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5: 857-866, 2005.
96. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, and Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324: 1713-1716, 2009.
97. Graham BH, Waymire KG, Cottrell B, Trounce IA, Mac-Gregor GR, and Wallace DC. A mouse model for mito-chondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nu-cleotide translocator. Nat Genet 16: 226-234, 1997.
98. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, and Brunet A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282: 30107-30119, 2007.
99. Griguer CE, Oliva CR, and Gillespie GY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neurooncol 74: 123-133, 2005.
100. Gstraunthaler G, Seppi T, and Pfaller W. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic? Cell Physiol Biochem 9: 150-172, 1999.
101. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, and Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 400: 464-468, 1999.
102. Halliwell B. Oxidative stress in cell culture: an underappreciated problem? FEBS Lett 540: 3-6, 2003.
103. Hamanaka RB and Chandel NS. Targeting glucose metabolism for cancer therapy. J Exp Med 209: 211-215, 2012.
104. Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA, Wibom R, and Larsson NG. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci USA 101: 3136-3141, 2004.
105. Hao W, Chang CP, Tsao CC, and Xu J. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J Biol Chem 285: 12647-12654, 2010.
106. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785, 2007.
107. Hardie DG, Carling D, and Gamblin SJ. AMP-activated protein kinase: also regulated by ADP? Trends Biochem Sci 36: 470-477, 2011.
108. Hardie DG, Scott JW, Pan DA, and Hudson ER. Management of cellular energy by the AMP-activated protein ki-nase system. FEBS Lett 546: 113-120, 2003.
109. Heerdt BG, Houston MA, and Augenlicht LH. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res 65: 9861-9867, 2005.
110. Heinrich R and Rapoport T. Linear theory of enzymatic chain: its application for analysis of the crossover theorem and of the glycolisis of human erytrocyte. Acta Biol Med Germ 31: 479-494, 1973.
111. Heinrich R and Rapoport T. Mathematical anlysis of mul-tienzyme systems. III. Steady-state and transient control. Biosystems 7: 130-136, 1975.
112. Heinrich R and Rapoport TA. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur J Biochem 42: 89-95, 1974.
113. Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, and Bolanos JP. The bioenergetic and antioxi-dant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nature Cell Biol 11: 747-752, 2009.
114. Hershko A and Ciechanover A. The ubiquitin system. Ann Rev Biochem 67: 425-479, 1998.
115. Hervouet E, Cizkova A, Demont J, Vojtiskova A, Pecina P, Franssen-van Hal NL, Keijer J, Simonnet H, Ivanek R, Kmoch S, Godinot C, and Houstek J. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 29: 1528-1537, 2008.
116. Hickson-Bick DL, Jones C, and Buja LM. Stimulation of mitochondrial biogenesis and autophagy by lipopolysac-charide in the neonatal rat cardiomyocyte protects against programmed cell death. J Mol Cell Cardiol 44: 411-418, 2008.
117. Hock MB and Kralli A. Transcriptional control of mito-chondrial biogenesis and function. Annu Rev Physiol 71: 177-203, 2009.
118. Hollis VS, Palacios-Callender M, Springett RJ, Delpy DT, and Moncada S. Monitoring cytochrome redox changes in the mitochondria of intact cells using multi-wavelength visible light spectroscopy. Biochim Biophys Acta 1607: 191-202, 2003.
119. Hood DA, Irrcher I, Ljubicic V, and Joseph AM. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209: 2265-2275, 2006.
120. Horvat S, Beyer C, and Susanne A. Effect of hypoxia on the transcription pattern of subunit isoforms and the kinetics of cytochrome c oxidase in cortical astrocytes and cerebellar neurons. J Neurochem 99: 937-951, 2006.
121. Hosgood HD, 3rd, Liu CS, Rothman N, Weinstein SJ, Bonner MR, Shen M, Lim U, Virtamo J, Cheng WL, Albanes D, and Lan Q. Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis 31: 847-849, 2010.
122. Hunte C, Zickermann V, and Brandt U. Functional modules and structural basis of conformational coupling in mitochondrial complex I. Science 329: 448-451, 2010.
123. Indran IR, Hande MP, and Pervaiz S. hTERT over-expression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 71: 266-276, 2011.
124. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, Xiao Y, Christie AL, Aster J, Settleman J, Gygi SP, Kung AL, Look T, Na-kayama KI, DePinho RA, and Wei W. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471: 104-109, 2011.
125. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yama-guchi A, Imanishi H, Nakada K, Honma Y, and Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664, 2008.
126. Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, and Jap BK. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science 281: 64-71, 1998.
127. Jeffree RL, Wills EJ, and Harper C. An unusual myopathy: speckled muscle fibers due to enlarged mitochondria. Muscle Nerve 36: 118-122, 2007.
128. Jendrach M, Mai S, Pohl S, Voth M, and Bereiter-Hahn J. Short-and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 8: 293-304, 2008.
129. Jose C, Bellance N, Chatelain EH, Benard G, Nouette-Gaulain K, and Rossignol R. Antiproliferative activity of levobupivacaine and aminoimidazole carboxamide ribo-nucleotide on human cancer cells of variable bioenergetic profile. Mitochondrion 12: 100-109, 2012.
130. Jose C, Bellance N, and Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 1807: 552-561, 2011.
131. Kacser H. The control of enzyme systems in vivo: elasticity analysis of the steady state. Biochem Soc Trans 11: 35-40, 1983.
132. Kacser H and Burns JA. The control of flux. Symp Soc Exp Biol 27: 65-104, 1973.
133. Kacser H and Porteous J. Control of metabolism: what do we have to measure? Trends Biochem Sci 12: 5-14, 1987.
134. Kanda Y and Watanabe Y. Thrombin-induced glucose transport via Src-p38 MAPK pathway in vascular smooth muscle cells. Br J Pharmacol 146: 60-67, 2005.
135. Karbowski M, Neutzner A, and Youle RJ. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 178: 71-84, 2007.
136. Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H, Shaw R, Brien TP, Bozzuto CD, Ooi D, Cantley LC, and Yuan J. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7: 1307-1319, 2001.
137. Kim I, Rodriguez-Enriquez S, and Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462: 245-253, 2007.
138. Kim JH, Kim HY, Lee YK, Yoon YS, Xu WG, Yoon JK, Choi SE, Ko YG, Kim MJ, Lee SJ, Wang HJ, and Yoon G. Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency. Autophagy 7: 1187-1198, 2011.
139. Kim JW, Tchernyshyov I, Semenza GL, and Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185, 2006.
140. King A, Selak MA, and Gottlieb E. Succinate dehydroge-nase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25: 4675-4682, 2006.
141. Koopman WJ, Distelmaier F, Hink MA, Verkaart S, Wijers M, Fransen J, Smeitink JA, and Willems PH. Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria. Am J Physiol Cell Physiol 294: C1124-C1132, 2008.
142. Koopman WJ, Hink MA, Verkaart S, Visch HJ, Smeitink JA, and Willems PH. Partial complex I inhibition decreases mitochondrial motility and increases matrix protein diffusion as revealed by fluorescence correlation spectroscopy. Biochim Biophys Acta 1767: 940-947, 2007.
143. Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, and Willems PH. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 12: 1431-1470, 2010.
144. Koopman WJ, Verkaart S, van Emst-de Vries SE, Grefte S, Smeitink JA, and Willems PH. Simultaneous quantification of oxidative stress and cell spreading using 5-(and-6)-chloromethyl-2¢, 7¢-dichlorofluorescein. Cytometry A 69: 1184-1192, 2006.
145. Koopman WJ, Verkaart S, Visch HJ, van der Westhuizen FH, Murphy MP, van den Heuvel LW, Smeitink JA, and Willems PH. Inhibition of complex I of the electron transport chain causes O2-.-mediated mitochondrial outgrowth. Am J Physiol Cell Physiol 288: C1440-C1450, 2005.
146. Koopman WJ, Visch HJ, Smeitink JA, and Willems PH. Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry A 69: 1-12, 2006.
147. Koopman WJ, Visch HJ, Verkaart S, van den Heuvel LW, Smeitink JA, and Willems PH. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol 289: C881-C890, 2005.
148. Koopman WJ, Willems PH, Oosterhof A, van Kuppevelt TH, and Gielen SC. Amplitude modulation of nuclear Ca2+ signals in human skeletal myotubes: a possible role for nuclear Ca2 + buffering. Cell Calcium 38: 141-152, 2005.
149. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, and Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321, 2002.
150. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, and Harris AL.
151. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, and Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 432: 1032-1036, 2004.
152. Kumar SH and Rangarajan A. Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol 83: 8565-8574, 2009.
153. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, and Auwerx J. Re-sveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122, 2006.
154. Lan Q, Lim U, Liu CS, Weinstein SJ, Chanock S, Bonner MR, Virtamo J, Albanes D, and Rothman N. A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma. Blood 112: 4247-4249, 2008.
155. Lebiedzinska M, Karkucinska-Wieckowska A, Giorgi C, Karczmarewicz E, Pronicka E, Pinton P, Duszynski J, Pro-nicki M, and Wieckowski MR. Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders. Biochim Biophys Acta 1797: 952-960, 2010.
156. Leonhard K, Herrmann JM, Stuart RA, Mannhaupt G, Neupert W, and Langer T. AAA proteases with catalytic sites on opposite membrane surfaces comprise a proteolytic system for the ATP-dependent degradation of inner membrane proteins in mitochondria. EMBO J 15: 4218-4229, 1996.
157. Lerebours A, Adam-Guillermin C, Brethes D, Frelon S, Floriani M, Camilleri V, Garnier-Laplace J, and Bourdi-neaud JP. Mitochondrial energetic metabolism perturbations in skeletal muscles and brain of zebrafish (Danio rerio) exposed to low concentrations of waterborne uranium. Aquat Toxicol 100: 66-74, 2010.
158. Letellier T, Heinrich R, Malgat M, and Mazat JP. The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J 302 (Pt 1): 171-174, 1994.
159. Leverve XM. Mitochondrial function and substrate availability. Crit Care Med 35: S454-S460, 2007.
160. Leverve XM and Fontaine E. Role of substrates in the regulation of mitochondrial function in situ. IUBMB Life 52: 221-229, 2001.
161. Liao LM, Baccarelli A, Shu XO, Gao YT, Ji BT, Yang G, Li HL, Hoxha M, Dioni L, Rothman N, Zheng W, and Chow WH. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev 20: 1944-1949, 2011.
162. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, and Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801, 2002.
163. Liu W, Acin-Perez R, Geghman KD, Manfredi G, Lu B, and Li C. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc Natl Acad Sci USA 108: 12920-12924, 2011.
164. Loiseau D, Chevrollier A, Douay O, Vavasseur F, Renier G, Reynier P, Malthiery Y, and Stepien G. Oxygen consumption and expression of the adenine nucleotide translocator in cells lacking mitochondrial DNA. Exp Cell Res 278: 12-18, 2002.
165. Lombes A, Mendell JR, Nakase H, Barohn RJ, Bonilla E, Zeviani M, Yates AJ, Omerza J, Gales TL, Nakahara K, et al. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol 26: 20-33, 1989.
166. Lopez-Rios F, Sanchez-Arago M, Garcia-Garcia E, Ortega AD, Berrendero JR, Pozo-Rodriguez F, Lopez-Encuentra A, Ballestin C, and Cuezva JM. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res 67: 9013-9017, 2007.
167. Lowe SW, Cepero E and Evan G. Intrinsic tumour suppression. Nature 432: 307-315, 2004.
168. Lu H, Forbes RA and Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277: 23111-23115, 2002.
169. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, and Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120: 237-248, 2005.
170. Lumini JA, Magalhaes J, Oliveira PJ, and Ascensao A. Beneficial effects of exercise on muscle mitochondrial function in diabetes mellitus. Sports Med 38: 735-750, 2008.
171. Lumini-Oliveira J, Magalhaes J, Pereira CV, Aleixo I, Oli-veira PJ, and Ascensao A. Endurance training improves gastrocnemius mitochondrial function despite increased susceptibility to permeability transition. Mitochondrion 9: 454-462, 2009.
172. Lynch SM, Weinstein SJ, Virtamo J, Lan Q, Liu CS, Cheng WL, Rothman N, and Albanes D, Stolzenberg-Solomon RZ. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila) 4: 1912-1919, 2011.
173. Maiuri MC, Criollo A, and Kroemer G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J 29: 515-516, 2010.
174. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, and Moreno-Sanchez R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084-1101, 2009.
175. Martins I, Galluzzi L, and Kroemer G. Hormesis, cell death and aging. Aging 3:821-828, 2011.
176. Mathupala SP, Rempel A, and Pedersen PL. Aberrant gly-colytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29: 339-343, 1997.
177. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gav-rilova O, Hurley PJ, Bunz F, and Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006.
178. Mazat JP, Rossignol R, Malgat M, Rocher C, Faustin B, and Letellier T. What do mitochondrial diseases teach us about normal mitochondrial functions that we already knew: threshold expression of mitochondrial defects. Biochim Biophys Acta 1504: 20-30, 2001.
179. Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 43: 969-980, 2010.
180. Meijer AJ and Codogno P. Autophagy: regulation by energy sensing. Curr Biol CB 21: R227-R229, 2011.
181. Mercy L, Pauw A, Payen L, Tejerina S, Houbion A, Demazy C, Raes M, Renard P, and Arnould T. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2+-depen-dent pathway and a reduced mitochondrial protein import. Febs J 272: 5031-5055, 2005.
182. Michel S, Wanet A, De Pauw A, Rommelaere G, Arnould T, and Renard P. Crosstalk between mitochondrial (dys)func-tion and mitochondrial abundance. J Cell Physiol227: 2297-2310, 2011.
183. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfert by a chemi-osmotic type of mechanism. Nature 191: 144-148, 1961.
184. Moiseeva O, Bourdeau V, Roux A, Deschenes-Simard X, and Ferbeyre G. Mitochondrial dysfunction contributes to onco-gene-induced senescence. Mol Cell Biol 29: 4495-4507, 2009.
185. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320: 1293-1299, 1989.
186. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, and DeBer-ardinis RJ. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481: 385-388, 2012.
187. Nakai T, Yasuhara T, Fujiki Y, and Ohashi A. Multiple genes, including a member of the AAA family, are essential for degradation of unassembled subunit 2 of cytochrome c oxi-dase in yeast mitochondria. Mol Cell Biol 15: 4441-4452, 1995.
188. Narendra D, Tanaka A, Suen DF, and Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803, 2008.
189. Narendra D, Tanaka A, Suen DF, and Youle RJ. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5: 706-708, 2009.
190. Niemann S and Muller U. Mutations in SDHC cause au-tosomal dominant paraganglioma, type 3. Nat Genet 26: 268-270, 2000.
191. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, and Shimizu S. Discovery of Atg5/Atg7- independent alternative mac-roautophagy. Nature 461: 654-658, 2009.
192. Noland RC, Hickner RC, Jimenez-Linan M, Vidal-Puig A, Zheng D, Dohm GL, and Cortright RN. Acute endurance exercise increases skeletal muscle uncoupling protein-3 gene expression in untrained but not trained humans. Metabolism 52: 152-158, 2003.
193. Nouette-Gaulain K, Jose C, Capdevila X, and Rossignol R. From analgesia to myopathy: when local anesthetics impair the mitochondrion. Int J Biochem Cell Biol 43: 14-19, 2011.
194. Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, Ro-zenknop A, Rogov V, Lohr F, Popovic D, Occhipinti A, Reichert AS, Terzic J, Dotsch V, Ney PA, and Dikic I. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 11: 45-51, 2010.
195. Oakhill JS, Steel R, Chen ZP, Scott JW, Ling N, Tam S, and Kemp BE. AMPK is a direct adenylate charge-regulated protein kinase. Science 332: 1433-1435, 2011.
196. Ohnami S, Matsumoto N, Nakano M, Aoki K, Nagasaki K, Sugimura T, Terada M, and Yoshida T. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Cancer Res 59: 5565-5571, 1999.
197. Okatsu K, Saisho K, Shimanuki M, Nakada K, Shitara H, Sou YS, Kimura M, Sato S, Hattori N, Komatsu M, Tanaka K, and Matsuda N. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells 15: 887-900, 2010.
198. Okorokov AL and Milner J. An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes. Mol Cell Biol 19: 7501-7510, 1999.
199. Okunieff P, Vaupel P, Sedlacek R, and Neuringer LJ. Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry. Int J Radiat Oncol Biol Phys 16:1493-1500, 1989.
200. Papandreou I, Cairns RA, Fontana L, Lim AL, and Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197, 2006.
201. Park JY, Wang PY, Matsumoto T, Sung HJ, Ma W, Choi JW, Anderson SA, Leary SC, Balaban RS, Kang JG, and Hwang PM. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res 105: 705-712, 11 p following 712, 2009.
202. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, and Campisi J. Oxygen sensitivity severely limits the rep-licative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747, 2003.
203. Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Sotgia F, and Lisanti MP. Warburg meets au-tophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 16: 1264-1284, 2011.
204. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, and Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107, 2009.
205. Pedersen PL, Greenawalt JW, Chan TL, and Morris HP. A comparison of some ultrastructural and biochemical properties of mitochondria from Morris hepatomas 9618A, 7800, and 3924A. Cancer Res 30: 2620-2626, 1970.
206. Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, Zhang W, Plunkett W, and Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175: 913-923, 2006.
207. Peres S, Beurton-Aimar M, and Mazat JP. Pathway classification of TCA cycle. Syst Biol 153: 369-371, 2006.
208. Peres S, Vallee F, Beurton-Aimar M, and Mazat JP. ACoM: a classification method for elementary flux modes based on motif finding. Bio Syst 103: 410-419, 2011.
209. Perry CG, Lally J, Holloway GP, Heigenhauser GJ, Bonen A, and Spriet LL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol 588: 4795-4810, 2010.
210. Piccoli C, Scrima R, Boffoli D, and Capitanio N. Control by cytochrome c oxidase of the cellular oxidative phosphory-lation system depends on the mitochondrial energy state. Biochem J 396: 573-583, 2006.
211. Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X, Palacin M, and Zorzano A. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 14: 1405-1415, 2005.
212. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieck-owski MR, Del Sal G, Pelicci PG, and Rizzuto R. Protein kinase C beta and prolyl isomerase 1 regulate mitochon-drial effects of the life-span determinant p66Shc. Science 315: 659-663, 2007.
213. Plecita-Hlavata L, Lessard M, Santorova J, Bewersdorf J, and Jezek P. Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochon-drial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. Biochim Biophys Acta 1777: 834-846, 2008.
214. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wor-tham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Har-greaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, and Tomlinson IP. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14: 2231-2239, 2005.
215. Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, and Martinou JC. Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ 12: 1613-1621, 2005.
216. Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, and Jaakkola PM. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 28: 334-344, 2009.
217. Radoshevich L, Murrow L, Chen N, Fernandez E, Roy S, Fung C, and Debnath J. ATG12 conjugation to ATG3 regulates mitochondrial homeostasy and cell death. Cell 142: 590-600, 2010.
218. Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, and Klein C. Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS One 6: e16746, 2011.
219. Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, and Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci USA 107: 726-731, 2010.
220. Reitzer L, Wice B, and Kennel D. Evidence that glutamine, not sugar, is the major energy source for cultured Hela cells. JBC 254: 2669-2676, 1979.
221. Rezvani HR, Dedieu S, North S, Belloc F, Rossignol R, Letellier T, de Verneuil H, Taieb A, and Mazurier F. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem 282: 16413-16422, 2007.
222. Rezvani HR, Kim AL, Rossignol R, Ali N, Daly M, Mahfouf W, Bellance N, Taieb A, de Verneuil H, Mazurier F, and Bickers DR. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest 121: 195-211, 2011.
223. Rezvani HR, Rossignol R, Ali N, Benard G, Tang X, Yang HS, Jouary T, de Verneuil H, Taieb A, Kim AL, and Ma-zurier F. XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochim Biophys Acta 1807: 609-619, 2011.
224. Rodriguez-Enriquez S, Juarez O, Rodriguez-Zavala JS, and Moreno-Sanchez R. Multisite control of the Crabtree effect in ascites hepatoma cells. Eur J Biochem 268: 2512-2519, 2001.
225. Rodriguez-Hernandez A, Cordero MD, Salviati L, Artuch R, Pineda M, Briones P, Gomez Izquierdo L, Cotan D, Navas P, and Sanchez-Alcazar JA. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autop-hagy 5: 19-32, 2009.
226. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T. Mitochondrial threshold effects. Biochem J 370: 751-762, 2003.
227. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, and Capaldi RA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985-993, 2004.
228. Rugarli EI and Langer T. Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. Trends Mol Med 12: 262-269, 2006.
229. Salway JG. Metabolism at a Glance. Blacwell Publishing, London, 2010.
230. Sasabe E, Yang Z, Ohno S, and Yamamoto T. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible fac-tor-1alpha expression in oral squamous cell carcinoma cells. Free Radic Biol Med 48: 1321-1329, 2010.
231. Schafer JR, Fell DA, Rothman D, and Shulman RG. Protein phosphorylation can regulate metabolite concentrations rather than control flux: the example of glycogen synthase. Proc Natl Acad Sci USA 101: 1485-1490, 2004.
232. Scherz-Shouval R, Shvets E, and Elazar Z. Oxidation as a post-translational modification that regulates autophagy. Autophagy 3: 371-373, 2007.
233. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, and Elazar Z. Reactive oxygen species are essential for autop-hagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007.
234. Schrauwen P and Hesselink M. Uncoupling protein 3 and physical activity: the role of uncoupling protein 3 in energy metabolism revisited. Proc Nutr Soc 62: 635-643, 2003.
235. Schwimmer C, Lefebvre-Legendre L, Rak M, Devin A, Slonimski PP, di Rago JP, and Rigoulet M. Increasing mi-tochondrial substrate-level phosphorylation can rescue respiratory growth of an ATP synthase-deficient yeast. J Biol Chem 280: 30751-30759, 2005.
236. Semenza GL. Oxygen-dependent regulation of mitochon-drial respiration by hypoxia-inducible factor 1. Biochem J 405: 1-9, 2007.
237. Sgarbi G, Casalena GA, Baracca A, Lenaz G, DiMauro S, and Solaini G. Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/ aspartate: a potential new therapy. Arch Neurol 66: 951-957, 2009.
238. Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 18: 598-608, 2006.
239. Shen J, Platek M, Mahasneh A, Ambrosone CB, and Zhao H. Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 10: 62-68, 2010.
240. Sherr CJ and DePinho RA. Cellular senescence: mitotic clock or culture shock? Cell 102: 407-410, 2000.
241. Shi DY, Xie FZ, Zhai C, Stern JS, Liu Y, and Liu SL. The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol Cancer 8: 32, 2009.
242. Shoubridge EA, Karpati G, and Hastings KE. Deletion mutants are functionally dominant over wild-type mito-chondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 62: 43-49, 1990.
243. Smolkova K, Bellance N, Scandurra F, Genot E, Gnaiger E, Plecita-Hlavata L, Jezek P, and Rossignol R. Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr 42: 55-67, 2010.
244. Smolkova K, Plecita-Hlavata L, Bellance N, Benard G, Rossignol R, and Jezek P. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol 43: 950-968, 2011.
245. Soriano FX, Liesa M, Bach D, Chan DC, Palacin M, and Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 55: 1783-1791, 2006.
246. Spiegelman BM. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. No-vartis Found Symp 287: 60-63; discussion 63-69, 2007.
247. Steglich G, Neupert W, and Langer T. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol Cell Biol 19: 3435-3442, 1999.
248. Sterky FH, Lee S, Wibom R, Olson L, and Larsson NG. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci USA 108: 12937-12942, 2011.
249. Suski JM, Lebiedzinska M, Bonora M, Pinton P, Duszynski J, and Wieckowski MR. Relation between mitochondrial membrane potential and ROS formation. Methods Mol Biol 810: 183-205, 2012.
250. Sutovsky P, Van Leyen K, McCauley T, Day BN, and Sutovsky M. Degradation of paternal mitochondria after fertilization: implications for heteroplasmy, assisted reproductive technologies and mtDNA inheritance. Reprod Biomed Online 8: 24-33, 2004.
251. Suzuki T, Murakami T, Iino R, Suzuki J, Ono S, Shirakihara Y, and Yoshida M. F0F1-ATPase/synthase is geared to the synthesis mode by conformational rearrangement of epsilon subunit in response to proton motive force and ADP/ATP balance. J Biol Chem 278: 46840-46846, 2003.
252. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, and Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999.
253. Talbot DA, Lambert AJ, and Brand MD. Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3. FEBS Lett 556: 111-115, 2004.
254. Tan c. The Cell Biology of the Mitochondrial Protein IF1. University College London, 2011.
255. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, and Youle RJ. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191: 1367-1380, 2010.
256. Tang F, Wang B, Li N, Wu Y, Jia J, Suo T, Chen Q, Liu YJ, and Tang J. RNF185, a Novel MITOCHONDRIAL Ubi-quitin E3 Ligase, Regulates Autophagy through Interaction with BNIP1. PLoS One 6: e24367, 2011.
257. Tasdemir E, Maiuri MC, Tajeddine N, Vitale I, Criollo A, Vicencio JM, Hickman JA, Geneste O, and Kroemer G. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy. Cell Cycle 6: 2263-2267, 2007.
258. Teckman JH, An JK, Blomenkamp K, Schmidt B, and Perlmutter D. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency. Am J Physiol Gas-trointest Liver Physiol 286: G851-G862, 2004.
259. Telang S, Lane AN, Nelson KK, Arumugam S, and Ches-ney J. The oncoprotein H-RasV12 increases mitochondrial metabolism. Mol Cancer 6: 77, 2007.
260. Trian T, Benard G, Begueret H, Rossignol R, Girodet PO, Ghosh D, Ousova O, Vernejoux JM, Marthan R, Tunon-de-Lara JM, and Berger P. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 204: 3173-3181, 2007.
261. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004.
262. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, and Shirihai OS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27: 433-446, 2008.
263. Um SH, D'Alessio D, and Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3: 393-402, 2006.
264. van Beek JH, Hauschild AC, Hettling H, and Binsl TW. Robust modelling, measurement and analysis of human and animal metabolic systems. Philos Transact A Math Phys Eng Sci 367: 1971-1992, 2009.
265. Vanhaesebroeck B and Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 (Pt 3): 561-576, 2000.
266. Vankoningsloo S, De Pauw A, Houbion A, Tejerina S, De-mazy C, de Longueville F, Bertholet V, Renard P, Remacle J, Holvoet P, Raes M, and Arnould T. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J Cell Sci 119: 1266-1282, 2006.
267. Vaughn AE and Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox in-activation of cytochrome c. Nat Cell Biol 10: 1477-1483, 2008.
268. Vaupel P. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist 13 Suppl 3: 21-26, 2008.
269. Vaupel P, Hockel M, and Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Anti-oxid Redox Signal 9: 1221-1235, 2007.
270. Vaupel P and Mayer A. Effects of anemia and hypoxia on tumor biology. In: Anemia in Cancer. European Scholl of Oncology Scientific Updates, edited by Bokemeyer C and Ludwig H. New York: Elsevier Science, 2005, pp. 47-54.
271. Vaupel P, Mayer A, Briest S, and Hockel M. Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res 63: 7634-7637, 2003.
272. Verkaart S, Koopman WJ, Cheek J, van Emst-de Vries SE, van den Heuvel LW, Smeitink JA, and Willems PH. Mi-tochondrial and cytosolic thiol redox state are not detec-tably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. Biochim Biophys Acta 1772: 1041-1051, 2007.
273. Verkaart S, Koopman WJ, van Emst-de Vries SE, Nijtmans LG, van den Heuvel LW, Smeitink JA, and Willems PH. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim Biophys Acta 1772: 373-381, 2007.
274. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, and Pajonk F. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci USA 108: 16062-16067, 2011.
275. Votyakova TV and Reynolds IJ. DeltaPsi(m)-Dependent and-independent production of reactive oxygen species by rat brain mitochondria. J Neurochem 79: 266-277, 2001.
276. Wallace D. Mitochondrial diseases in man and mouse. Science 283: 1482-1488, 1999.
277. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, and Larner AC. Function of mitochondrial Stat3 in cellular respiration. Science 323: 793-797, 2009.
278. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, and Chandel NS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 107: 8788-8793, 2010.
279. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, and Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324: 1076-1080, 2009.
280. Wigfield SM, Winter SC, Giatromanolaki A, Taylor J, Koukourakis ML, and Harris AL. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer. Br J Cancer 98: 1975-1984, 2008.
281. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMa-hon SB, and Thompson CB. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105: 18782-18787, 2008.
282. Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, Burden SJ, Oldfors A, Westerblad H, and Larsson NG. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci USA 99: 15066-15071, 2002.
283. Wu Z, Huang X, Feng Y, Handschin C, Gullicksen PS, Bare O, Labow M, Spiegelman B, and Stevenson SC. Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci USA 103: 14379-14384, 2006.
284. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, Saiu P, Howell SA, Aasland R, Martin SR, Carling D, and Gamblin SJ. Structure of mammalian AMPK and its regulation by ADP. Nature 472: 230-233, 2011.
285. Xu S, Peng G, Wang Y, Fang S, and Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol Biol Cell 22: 291-300, 2011.
286. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, and Bigner DD. IDH1 and IDH2 mutations in gliomas. N Engl J Med 360: 765-773, 2009.
287. Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, and DeBerardinis RJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res 69: 7986-7993, 2009.
288. Yu T, Robotham JL, and Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103: 2653-2658, 2006.
289. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Ra-jagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S, Diaz LA, Jr., Velculescu VE, Lengauer C, Kinzler KW, Vogelstein B, and Papadopoulos N. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325: 1555-1559, 2009.
290. Zhang BB and Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9: 407-416, 2009.
291. Zhang C, Lin M, Wu R, Wang X, Yang B, Levine AJ, Hu W and Feng Z. Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci USA 108: 16259-16264, 2011.
292. Zhou S, Kachhap S, and Singh KK. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 18: 287-292, 2003.